# language_name_wals:	English
# language_name_glotto:	English
# iso639_3:	eng
# year_composed:	NA
# year_published:	NA
# mode:	written
# genre_broad:	technical
# genre_narrow:	NA
# writing_system:	Latn
# special_characters:	NA
# short_description:	EMEA
# source:	https://object.pouta.csc.fi/OPUS-EMEA/v3/raw/en.zip
# copyright_short:	http://opus.nlpl.eu/EMEA.php
# copyright_long:	http://opus.nlpl.eu/EMEA.php J. Tiedemann, 2012, Parallel Data, Tools and Interfaces in OPUS. In Proceedings of the 8th International Conference on Language Resources and Evaluation (LREC 2012)
# sample_type:	whole
# comments:	NA

EU Number
Invented name
Strength
Pharmaceutical Form
Route of Administration
Packaging
Content (concentration
Package size
EU/ 1/ 00/ 132/ 001
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (50 µg/ 0.5 ml)
1 vial + 1 ampoule
EU/ 1/ 00/ 132/ 002
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (50 µg/ 0.5 ml)
1 vial + 1 ampoule + 1 injection set1
EU/ 1/ 00/ 132/ 003
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (50 µg/ 0.5 ml)
4 vials + 4 ampoules
EU/ 1/ 00/ 132/ 004
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (50 µg/ 0.5 ml)
4 vials + 4 ampoules + 4 injection sets1
EU/ 1/ 00/ 132/ 005
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (50 µg/ 0.5 ml)
6 vials + 6 ampoules
EU/ 1/ 00/ 132/ 006
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (80 µg/ 0.5 ml)
1 vial + 1 ampoule
EU/ 1/ 00/ 132/ 007
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (80 µg/ 0.5 ml)
1 vial + 1 ampoule + 1 injection set1
EU/ 1/ 00/ 132/ 008
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (80 µg/ 0.5 ml)
4 vials + 4 ampoules
EU/ 1/ 00/ 132/ 009
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (80 µg/ 0.5 ml)
4 vials + 4 ampoules + 4 injection sets1
EU/ 1/ 00/ 132/ 010
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (80 µg/ 0.5 ml)
6 vials + 6 ampoules
1/ 6 EU Number
Invented name
Strength
Pharmaceutical Form
Route of Administration
Packaging
Content (concentration
Package size
EU/ 1/ 00/ 132/ 011
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (100 µg/ 0.5 ml)
1 vial + 1 ampoule
EU/ 1/ 00/ 132/ 012
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (100 µg/ 0.5 ml)
1 vial + 1 ampoule + 1 injection set1
EU/ 1/ 00/ 132/ 013
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (100 µg/ 0.5 ml)
4 vials + 4 ampoules
EU/ 1/ 00/ 132/ 014
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (100 µg/ 0.5 ml)
4 vials + 4 ampoules + 4 injection sets1
EU/ 1/ 00/ 132/ 015
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (100 µg/ 0.5 ml)
6 vials + 6 ampoules
EU/ 1/ 00/ 132/ 016
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (120 µg/ 0.5 ml)
1 vial + 1 ampoule
EU/ 1/ 00/ 132/ 017
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (120 µg/ 0.5 ml)
1 vial + 1 ampoule + 1 injection set1
EU/ 1/ 00/ 132/ 018
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (120 µg/ 0.5 ml)
4 vials + 4 ampoules
EU/ 1/ 00/ 132/ 019
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (120 µg/ 0.5 ml)
4 vials + 4 ampoules + 4 injection sets1
EU/ 1/ 00/ 132/ 020
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (120 µg/ 0.5 ml)
6 vials + 6 ampoules
2/ 6 EU Number
Invented name
Strength
Pharmaceutical Form
Route of Administration
Packaging
Content (concentration
Package size
EU/ 1/ 00/ 132/ 021
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (150 µg/ 0.5 ml)
1 vial + 1 ampoule
EU/ 1/ 00/ 132/ 022
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (150 µg/ 0.5 ml)
1 vial + 1 ampoule + 1 injection set1
EU/ 1/ 00/ 132/ 023
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (150 µg/ 0.5 ml)
4 vials + 4 ampoules
EU/ 1/ 00/ 132/ 024
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (150 µg/ 0.5 ml)
4 vials + 4 ampoules + 4 injection sets1
EU/ 1/ 00/ 132/ 025
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (150 µg/ 0.5 ml)
6 vials + 6 ampoules
EU/ 1/ 00/ 132/ 026
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (50 µg/ 0.5 ml)
12 vials + 12 ampoules + 12 injection sets1
EU/ 1/ 00/ 132/ 027
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (80 µg/ 0.5 ml)
12 vials + 12 ampoules + 12 injection sets1
EU/ 1/ 00/ 132/ 028
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (100 µg/ 0.5 ml)
12 vials + 12 ampoules + 12 injection sets1
EU/ 1/ 00/ 132/ 029
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (120 µg/ 0.5 ml)
12 vials + 12 ampoules + 12 injection sets1
EU/ 1/ 00/ 132/ 030
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
powder: vial (glass); solvent: ampoule (glass)
0.7 ml (150 µg/ 0.5 ml)
12 vials + 12 ampoules + 12 injection sets1
3/ 6 EU Number
Invented name
Strength
Pharmaceutical Form
Route of Administration
Packaging
Content (concentration
Package size
EU/ 1/ 00/ 132/ 031
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (50 µg/ 0.5 ml)
1 pen + 1 injection needle + 2 cleansing swabs
EU/ 1/ 00/ 132/ 032
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (50 µg/ 0.5 ml)
4 pens + 4 injection needles + 8 cleansing swabs
EU/ 1/ 00/ 132/ 033
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (50 µg/ 0.5 ml)
6 pens + 6 injection needles + 12 cleansing swabs
EU/ 1/ 00/ 132/ 034
ViraferonPeg
50 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (50 µg/ 0.5 ml)
12 pens + 12 injection needles + 24 cleansing swabs
EU/ 1/ 00/ 132/ 035
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (80 µg/ 0.5 ml)
1 pen + 1 injection needle + 2 cleansing swabs
EU/ 1/ 00/ 132/ 036
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (80 µg/ 0.5 ml)
4 pens + 4 injection needles + 8 cleansing swabs
EU/ 1/ 00/ 132/ 037
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (80 µg/ 0.5 ml)
6 pens + 6 injection needles + 12 cleansing swabs
EU/ 1/ 00/ 132/ 038
ViraferonPeg
80 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (80 µg/ 0.5 ml)
12 pens + 12 injection needles + 24 cleansing swabs
EU/ 1/ 00/ 132/ 039
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (100 µg/ 0.5 ml)
1 pen + 1 injection needle + 2 cleansing swabs
EU/ 1/ 00/ 132/ 040
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (100 µg/ 0.5 ml)
4 pens + 4 injection needles + 8 cleansing swabs
4/ 6 EU Number
Invented name
Strength
Pharmaceutical Form
Route of Administration
Packaging
Content (concentration
Package size
EU/ 1/ 00/ 132/ 041
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (100 µg/ 0.5 ml)
6 pens + 6 injection needles + 12 cleansing swabs
EU/ 1/ 00/ 132/ 042
ViraferonPeg
100 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (100 µg/ 0.5 ml)
12 pens + 12 injection needles + 24 cleansing swabs
EU/ 1/ 00/ 132/ 043
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (120 µg/ 0.5 ml)
1 pen + 1 injection needle + 2 cleansing swabs
EU/ 1/ 00/ 132/ 044
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (120 µg/ 0.5 ml)
4 pens + 4 injection needles + 8 cleansing swabs
EU/ 1/ 00/ 132/ 045
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (120 µg/ 0.5 ml)
6 pens + 6 injection needles + 12 cleansing swabs
EU/ 1/ 00/ 132/ 046
ViraferonPeg
120 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (120 µg/ 0.5 ml)
12 pens + 12 injection needles + 24 cleansing swabs
EU/ 1/ 00/ 132/ 047
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (150 µg/ 0.5 ml)
1 pen + 1 injection needle + 2 cleansing swabs
EU/ 1/ 00/ 132/ 048
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (150 µg/ 0.5 ml)
4 pens + 4 injection needles + 8 cleansing swabs
EU/ 1/ 00/ 132/ 049
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (150 µg/ 0.5 ml)
6 pens + 6 injection needles + 12 cleansing swabs
EU/ 1/ 00/ 132/ 050
ViraferonPeg
150 micrograms
Powder and solvent for solution for injection
Subcutaneous use
pre-filled pen (cartridge, glass) Solvent: ampoule (glass)
0.5 ml (150 µg/ 0.5 ml)
12 pens + 12 injection needles + 24 cleansing swabs
5/ 6 1 Injection set = injection syringe + 2 injection needles + cleansing swab.
6/ 6